Ignite Creation Date:
2025-12-18 @ 8:44 AM
Ignite Modification Date:
2025-12-18 @ 8:44 AM
Study NCT ID:
NCT02799771
Status:
None
Last Update Posted:
2022-08-03 00:00:00
First Post:
2016-06-06 00:00:00
Is Possible Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
HYPID (Pulmonary Hypertension in Interstitial Lung Disease) EXTENSION
Sponsor:
None
Organization:
Study Overview
Official Title:
Observational Study of Incident Patients With Pre Capillary Pulmonary Hypertension and Interstitial Lung Disease
Status:
None
Status Verified Date:
2022-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
HYPID-2
Brief Summary:
Pre capillary pulmonary hypertension (PH) may be present in patients with diffuse interstitial lung disease.
In this context, PH represents an important factor of morbidity and mortality for these patients.
As in HYPID, the main purpose of HYPID-2 is to determine predictive factors of mortality within this cohort of incident patients (i.e patients included within 6 months after PH diagnosis).
In order to reach that aim,the study includes an evaluation based on exams conducted for the routine follow-up of incident patients.
Each incident patient will be followed during 2 years at least.
In this context, PH represents an important factor of morbidity and mortality for these patients.
As in HYPID, the main purpose of HYPID-2 is to determine predictive factors of mortality within this cohort of incident patients (i.e patients included within 6 months after PH diagnosis).
In order to reach that aim,the study includes an evaluation based on exams conducted for the routine follow-up of incident patients.
Each incident patient will be followed during 2 years at least.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: